本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Xeris製藥

7.78
+0.29003.87%
盤後7.780.00000.00%17:26 EDT
成交量:203.49萬
成交額:1,585.06萬
市值:14.18億
市盈率:-76.27
高:7.92
開:7.50
低:7.50
收:7.49
52周最高:10.08
52周最低:5.25
股本:1.82億
流通股本:1.73億
量比:0.98
換手率:1.18%
股息:- -
股息率:- -
每股收益(TTM):-0.1020
每股收益(LYR):0.0032
淨資產收益率:-617.16%
總資產收益率:6.13%
市淨率:-145.72
市盈率(LYR):2,425.94

資料載入中...

2026/03/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2025/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

重要事件披露

Form 8-K - Current report
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]